BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Désert R, Nieto N, Musso O. Dimensions of hepatocellular carcinoma phenotypic diversity. World J Gastroenterol 2018; 24(40): 4536-4547 [PMID: 30386103 DOI: 10.3748/wjg.v24.i40.4536]
URL: https://www.wjgnet.com/1007-9327/full/v24/i40/4536.htm
Number Citing Articles
1
Natalia I. Krupenko, Jaspreet Sharma, Halle M. Fogle, Peter Pediaditakis, Kyle C. Strickland, Xiuxia Du, Kristi L. Helke, Susan Sumner, Sergey A. Krupenko. Knockout of Putative Tumor Suppressor Aldh1l1 in Mice Reprograms Metabolism to Accelerate Growth of Tumors in a Diethylnitrosamine (DEN) Model of Liver CarcinogenesisCancers 2021; 13(13): 3219 doi: 10.3390/cancers13133219
2
Lise Desquilles, Luis Cano, Gevorg Ghukasyan, Nicolas Mouchet, Clémence Landreau, Anne Corlu, Bruno Clément, Bruno Turlin, Romain Désert, Orlando Musso. Well-differentiated liver cancers reveal the potential link between ACE2 dysfunction and metabolic breakdownScientific Reports 2022; 12(1) doi: 10.1038/s41598-021-03710-0
3
Xianpeng Li, Huaixi Yu, Feng Xu, Yifeng Wu, Jifang Sheng, Kai Zheng. Differentially Expressed Long Noncoding RNAs Involved in FUBP1 Promoting Hepatocellular Carcinoma Cells ProliferationBioMed Research International 2021; 2021: 1 doi: 10.1155/2021/6664519
4
Wai Har Ng, Khee Chee Soo, Hung Huynh. Vinorelbine Improves the Efficacy of Sorafenib against Hepatocellular Carcinoma: A Promising Therapeutic ApproachInternational Journal of Molecular Sciences 2024; 25(3): 1563 doi: 10.3390/ijms25031563
5
Vladimir M. Subbotin. A hypothesis on paradoxical privileged portal vein metastasis of hepatocellular carcinoma. Can organ evolution shed light on patterns of human pathology, and vice versa?Medical Hypotheses 2019; 126: 109 doi: 10.1016/j.mehy.2019.03.019
6
Daniel Neureiter, Sebastian Stintzing, Tobias Kiesslich, Matthias Ocker. Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targetsWorld Journal of Gastroenterology 2019; 25(25): 3136-3150 doi: 10.3748/wjg.v25.i25.3136
7
Anna Gajos-Michniewicz, Malgorzata Czyz. WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunitiesGenes & Diseases 2024; 11(2): 727 doi: 10.1016/j.gendis.2023.02.050
8
Haruhiko Takeda, Atsushi Takai, Yuji Eso, Ken Takahashi, Hiroyuki Marusawa, Hiroshi Seno. Genetic Landscape of Multistep HepatocarcinogenesisCancers 2022; 14(3): 568 doi: 10.3390/cancers14030568
9
Satoyoshi Yamashita, Akira Kato, Toshitaka Akatsuka, Takashi Sawada, Tomohide Asai, Noriyuki Koyama, Kiwamu Okita. Clinical relevance of increased serum preneoplastic antigen in hepatitis C-related hepatocellular carcinomaWorld Journal of Gastroenterology 2020; 26(13): 1463-1473 doi: 10.3748/wjg.v26.i13.1463
10
Grant Tarnow, Rachel Matrenec, Claudia E. Oropeza, Mark Maienschein-Cline, Alan McLachlan. Distinct phenotypic spectra of hepatocellular carcinoma in liver-specific tumor suppressor-deficient hepatitis B virus transgenic miceVirology 2022; 574: 84 doi: 10.1016/j.virol.2022.08.002
11
Hung Huynh, Wai Har Ng, Khee Chee Soo. Everolimus Acts in Synergy with Vinorelbine to Suppress the Growth of Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2023; 25(1): 17 doi: 10.3390/ijms25010017
12
Romain Desert, Xiaodong Ge, Zhuolun Song, Hui Han, Daniel Lantvit, Wei Chen, Sukanta Das, Dipti Athavale, Ioana Abraham‐Enachescu, Chuck Blajszczak, Yu Chen, Orlando Musso, Grace Guzman, Yujin Hoshida, Natalia Nieto. Role of Hepatocyte‐Derived Osteopontin in Liver CarcinogenesisHepatology Communications 2022; 6(4): 692 doi: 10.1002/hep4.1845
13
Yoann Daniel, Elise Lelou, Caroline Aninat, Anne Corlu, Florian Cabillic. Interplay between Metabolism Reprogramming and Epithelial-to-Mesenchymal Transition in Cancer Stem CellsCancers 2021; 13(8): 1973 doi: 10.3390/cancers13081973
14
Evin Iscan, Umut Ekin, Gokhan Yildiz, Ozden Oz, Umur Keles, Aslı Suner, Gulcin Cakan-Akdogan, Gunes Ozhan, Marta Nekulova, Borivoj Vojtesek, Hamdiye Uzuner, Gökhan Karakülah, Hani Alotaibi, Mehmet Ozturk. TAp73β Can Promote Hepatocellular Carcinoma DedifferentiationCancers 2021; 13(4): 783 doi: 10.3390/cancers13040783
15
Claudia E. Oropeza, Caitlin R. Ondracek, Grant Tarnow, Mark Maienschein-Cline, Stefan J. Green, Alan McLachlan. Heterogeneous phenotypes of Pten-null hepatocellular carcinoma in hepatitis B virus transgenic mice parallels liver lobule zonal gene expression patternsVirology 2022; 566: 16 doi: 10.1016/j.virol.2021.11.007
16
Srinivas Reddy Pallerla, Nghiem Xuan Hoan, Sivaramakrishna Rachakonda, Christian G. Meyer, Hoang Van Tong, Nguyen Linh Toan, Le Thi Kieu Linh, Dao Phuong Giang, Peter G. Kremsner, Mai Hong Bang, Le Huu Song, Thirumalaisamy P. Velavan. Custom gene expression panel for evaluation of potential molecular markers in hepatocellular carcinomaBMC Medical Genomics 2022; 15(1) doi: 10.1186/s12920-022-01386-7
17
Guoming Deng, Yufeng Luo, Yaoming Zhang, Jinfeng Zhang, Zongyun He. Enabled homolog (ENAH) regulated by RNA binding protein splicing factor 3b subunit 4 (SF3B4) exacerbates the proliferation, invasion and migration of hepatocellular carcinoma cells via Notch signaling pathwayBioengineered 2022; 13(2): 2194 doi: 10.1080/21655979.2021.2023983
18
Romain Desert, Wei Chen, Xiaodong Ge, Roselyne Viel, Hui Han, Dipti Athavale, Sukanta Das, Zhuolun Song, Daniel Lantvit, Luis Cano, Alexandra Naba, Orlando Musso, Natalia Nieto. Hepatocellular carcinomas, exhibiting intratumor fibrosis, express cancer-specific extracellular matrix remodeling and WNT/TGFB signatures, associated with poor outcomeHepatology 2023; 78(3): 741 doi: 10.1097/HEP.0000000000000362